“Adaptive Licensing: Bane or Boon for Drug Development?”Chair: Dr. Hans-Georg Eichler (European Medicines Agency) and panelists – Dr. Thomas Unger (Pfizer), Dr. Kenneth Oye (MIT) and Dr. Robyn Lim (Health Canada)